Skip to main content
Toggle navigation
Login
Search
Home
32 Views
Favorite
Tweet
Print
Email
Hematopathology
(H049) KMT2A Fusion Detection for Measurable Residual Disease in Acute Myeloid Leukemia Using a Novel Multiplex Digital PCR Assay
Saturday, November 15, 2025
9:15 AM - 10:15 AM
EST
Speaker(s)
Matthew Holman (he/him/his)
Scientist
Invivoscribe, Inc.